Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00943254 · ClinicalTrials.gov registry record · NA
Metabolic Syndrome Diagnosis and Education Trial
A NA study of Metabolic Cardiovascular Syndrome, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 74
- Enrollment target
- 1
- Study location
NCT00943254 is a NA study of Metabolic Cardiovascular Syndrome that has completed, run by Mayo Clinic. The registered enrollment target is 74 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00943254, a NA study of Metabolic Cardiovascular Syndrome, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to gain knowledge on how effective different approaches of providing a diagnosis and varying educational tools that include DVDs and multimedia or printed instruction sheets on your readiness to increase the subject's level of exercise, lose more weight, eat a healthier diet; and to assess the subject's awareness of their risk of heart disease and their readiness to participate in a comprehensive lifestyle modification program.
Conditions Studied
Interventions
- OTHER High-Tech Education
- OTHER Low-Tech Education
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2007-10 |
| Est. Completion | 2010-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00943254
The ClinicalTrials.gov registry entry for NCT00943254 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Metabolic Cardiovascular Syndrome appearing as the primary indexed condition, and to 2 interventions - of which High-Tech Education is the first listed.
NCT00943254 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT00943254 about?
NCT00943254 is a clinical study titled "Metabolic Syndrome Diagnosis and Education Trial". This study is being done to gain knowledge on how effective different approaches of providing a diagnosis and varying educational tools that include DVDs and multimedia or printed instruction sheets on your readiness to increase the subject's level of exercise, lose more weight, eat a healthier diet...
What is the current status of trial NCT00943254?
This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2007-10. Estimated completion is 2010-08.
What conditions does trial NCT00943254 study?
This clinical trial studies the following conditions: Metabolic Cardiovascular Syndrome.
What interventions are being tested in trial NCT00943254?
The interventions under investigation include: High-Tech Education (OTHER), Low-Tech Education (OTHER).
Who is sponsoring clinical trial NCT00943254?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00943254 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolic Cardiovascular Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.